Kallikrein 9 anticorps (C-Term) (PE)

N° du produit ABIN8003946

L’anticorps anti-Kallikrein 9 Polyclonal Lapin est utilisé pour la détection de Kallikrein 9 dans des échantillons de Humain. Il a été validé pour FACS.

Aperçu rapide pour Kallikrein 9 anticorps (C-Term) (PE) (ABIN8003946)

Antigène: Kallikrein 9 (KLK9)

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Kallikrein 9 est conjugé à/à la PE

Application: Flow Cytometry (FACS)

Détail du produit anti-Kallikrein 9 anticorps (PE)

Épitope: C-Term

Fonction: Anti-Kallikrein 9/KLK9 Antibody PE Conjugated

Specificité: No cross reactivity with other proteins.

Réactivité croisée (Details): No cross-reactivity with other proteins

Purification: Immunogen affinity purified.

Immunogène: A synthetic peptide corresponding to a sequence at the C-terminus of human Kallikrein 9.

Isotype: IgG

Information d'application

Indications d'application: Flow Cytometry, Optimal dilutions should be determined by end users.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.

Date de péremption: 12 months

Détails sur Kallikrein 9

Antigène: Kallikrein 9 (KLK9)

Autre désignation: KLK9

Sujet:

Background: KLK9 (kallikrein-related peptidase 9) also known as kallikrein 9 or KLK-L3, belongs to the kallikrein subgroup of serine proteases, which have diverse physiologic functions in many tissues. The KLK9 gene contains 5 coding exons and is mapped to 19q13.41. The KLK9 gene is regulated by steroid hormones in a human breast cancer cell line. Yousef et al. (2001) performed a quantitative analysis of KLK9 expression in ovarian cancer. The results indicated thatKLK9 is under steroid hormone regulation in ovarian and breast cancer cell lines. KLK9 is a potential independent favorable prognostic marker for early-stage, low-grade, optimally debulked ovarian cancer patients.

Gene Full Name: kallikrein related peptidase 9

Sequence Similarities: Belongs to the peptidase S1 family. Kallikrein subfamily.

ID gène: 284366

UniProt: Q9UKQ9

Pathways: Système du Complément